ArticleScientific reports2022

Pharmacovigilance study of the association between dipeptidyl peptidase-4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS).

Katsuhiro Ohyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.